Glioma
The researchers are doing this study to find out whether the drugs ABBV‑637 and ABBV‑155 are safe treatments that cause few or mild side effects when given alone or in combination with ERAS‑801 in people with recurrent GBM.
UCLA Glioma Clinical Trials for 2026 – Los Angeles
Providing evidence of safety for novel therapies in recurrent glioblastoma could improve treatment options for patients with limited alternatives.
Bizonyítékszint: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Kapcsolódó jelek
- Phase 2b Trial for Cancer Vaccine in Newly Diagnosed Glioblastoma Will Continue
- Glioblastoma Clinical Trials for New Treatments
- Clinical trial links oncolytic immunoactivation to survival in glioblastoma
- Tumour treating fields therapy for glioblastoma: current advances and future directions
- Treating the invisible target: treatment planning targeting the microscopic tumor spread in gliomas